References

Management of Helicobacter pylori infections

10.1186/s12876-016-0496-2 · 2016 · External reference

Comparison of potassium-competitive acid blockers and proton pump inhibitors in patients with gastroesophageal reflux disease: a systematic review and meta-analysis of randomized controlled trials

10.7759/cureus.65141 · 2024 · External reference

Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps

10.1038/s41467-019-10050-1 · 2019 · External reference

The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stress

10.1038/s41467-020-18857-z · 2020 · External reference

Unlocking the path to efficient H. pylori eradication: embracing potassium-competitive acid blockers (P-CABs)

10.4103/sjg.sjg_297_23 · 2023 · External reference

Real-world situation of eradication regimens and risk factors for Helicobacter pylori treatment in China: a retrospective single-center study

10.2147/ceg.s466975 · 2024 · External reference

Comparative molecular profiling of Helicobacter pylori infection and antibiotic genotypic resistance in paired gastric mucosa, gastric juice, and stool samples

10.1038/s41598-025-32968-x · 2025 · External reference

ACG clinical guideline: treatment of Helicobacter pylori infection

10.14309/ajg.0000000000002968 · 2024 · External reference

Chinese consensus report on family-based Helicobacter pylori infection control and management (2021 edition)

10.1136/gutjnl-2021-325630 · 2022 · External reference

Whole-genome sequencing analyses and antibiotic resistance situation of 48 Helicobacter pylori strains isolated in Zhejiang, China

10.1186/s13099-024-00656-2 · 2024 · External reference

Helicobacter pylori antibiotic resistance in the United States between 2011 and 2021: a systematic review and meta-analysis

10.14309/ajg.0000000000001828 · 2022 · External reference

Eradication rates of Helicobacter pylori in treatment-naive patients following 14-day vonoprazan-amoxicillin dual therapy: a multicenter randomized controlled trial in China

10.1111/hel.12970 · 2023 · External reference

Higher dietary cholesterol and ω-3 fatty acid intakes are associated with a lower success rate of Helicobacter pylori eradication therapy in Japan

10.3945/ajcn.116.144873 · 2017 · External reference

A population-based Helicobacter pylori eradication strategy is more cost-effective than endoscopic screening

10.1007/s10620-022-07795-z · 2023 · External reference

Tailored therapy guided by genotypic resistance from gastric mucosa samples in the first-line treatment of Helicobacter pylori infection: a systematic review and meta-analysis

10.1177/17562848251348826 · 2025 · External reference

Empirical versus tailored therapy based on genotypic resistance detection for Helicobacter pylori eradication: a systematic review and meta-analysis

10.1177/17562848231196357 · 2023 · External reference

Economic evaluation of preventing gastric cancer by eliminating Helicobacter pylori infection in China

10.1080/00365521.2025.2473020 · 2025 · External reference

Gastritis in the alcoholic: relationship to gastric alcohol metabolism and Helicobacter pylori

10.1080/13556219871967 · 1998 · External reference

Fifth Chinese national consensus report on the management of Helicobacter pylori infection

10.1111/hel.12475 · 2018 · External reference

Management of Helicobacter pylori infection: the maastricht VI/Florence consensus report

10.1136/gutjnl-2022-327745 · 2022 · External reference

Multicentric cohort study on the long-term efficacy and safety of electronic cigarettes: study design and methodology

10.1186/1471-2458-13-883 · 2013 · External reference

Rates of antimicrobial resistance in Helicobacter pylori isolates from clinical trial patients across the US and Europe

10.14309/ajg.0000000000002045 · 2023 · External reference

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study

10.1136/gutjnl-2015-311304 · 2016 · External reference

Comparative efficacy and safety of potassium-competitive acid blockers and proton pump inhibitors for first-line Helicobacter pylori eradication therapy: a systematic review and network meta-analysis

10.1111/hel.13150 · 2024 · External reference

Clinical evaluation of personalized Helicobacter pylori treatment guided by PCR detection from fecal samples: a real-world study

10.3389/fcimb.2025.1519804 · 2025 · External reference

The Efficacy of Two Triple Therapy Regimens and One Quadruple Regimen [Omeprazole, Amoxicillin, Metronidazole with Bismuth] in Eradicating Helicobacter pylori in Patients with Peptic Ulcer: A Randomized Clinical Trial

10.2174/0115748871306001241017050020 · 2025 · External reference

Molecular characterization and mutational analysis of Clarithromycin- and levofloxacin-resistance genes in Helicobacter pylori from gastric biopsies in southern Croatia

10.3390/ijms241914560 · 2023 · External reference

Helicobacter pylori antibiotic resistance: a global challenge in search of solutions

10.1136/gutjnl-2025-335523 · 2025 · External reference

Understanding the Hawthorne effect

10.1136/bmj.h4672 · 2015 · External reference

Host genetic determinants associated with Helicobacter pylori eradication treatment failure: a systematic review and meta-analysis

10.1053/j.gastro.2021.07.043 · 2021 · External reference

Optimizing acid-related disease management: insights into potassium-competitive acid blockers and proton pump inhibitors

10.1007/s00228-025-03912-9 · 2025 · External reference

Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration

10.1371/journal.pmed.0040297 · 2007 · External reference

Sensitivity analysis in observational research: introducing the E-Value

10.7326/m16-2607 · 2017 · External reference

Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation

10.1136/gutjnl-2021-325948 · 2022 · External reference

Reinforced medication adherence improves Helicobacter pylori eradication rate in developing countries: a systematic review and meta-analysis of randomized controlled trials

10.1111/hel.12989 · 2023 · External reference

Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication

10.3748/wjg.v24.i40.4596 · 2018 · External reference

Comparison of tegoprazan-based and proton pump inhibitor-based regimens for Helicobacter pylori eradication: a meta-analysis and systematic review

10.3389/fmed.2025.1580203 · 2025 · External reference

2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment

10.1097/cm9.0000000000002546 · 2022 · External reference

Empirical therapy versus tailored therapy for Helicobacter pylori infection? A systematic review

10.1186/s12879-025-12289-0 · 2025 · External reference